logo

Pultegroup, Inc. (PHM)



Trade PHM now with
  Date
  Headline
2/19/2020 8:06:18 AM PulteGroup Sharing Its Top Trends To Look For In 2020
2/17/2020 2:33:42 AM PharmaMar And Jazz Pharma Announce FDA Acceptance And Priority Review Of NDA For Lurbinectedin
2/6/2020 12:14:01 PM PulteGroup, Inc. (PHM) Declares Quarterly Dividend of $ 0.12, Record Date 3/13/2020
2/6/2020 10:02:40 AM PulteGroup Declares Dividend Of $0.12/shr; Payable April 3/record March 13
1/28/2020 6:34:27 AM PulteGroup Acquires Innovative Construction Group; Terms Not Disclosed
1/28/2020 6:34:16 AM PulteGroup Q4 Adj. EPS $1.14, Consensus $1.09
1/22/2020 2:40:10 AM PharmaMar, Jazz U.S. License Agreement For Lurbinectedin Effective With Expiration Of HSR Waiting Period
12/19/2019 8:02:26 AM PharmaMar And Jazz Sign License Agreement For Lurbinectedin In U.S.; Jazz To Pay Upfront Payment Of $200 Mln
12/5/2019 8:41:54 AM PulteGroup, Inc. (PHM) Declares Quarterly Dividend of $ 0.12, Record Date 12/18/2019
12/5/2019 8:40:21 AM PulteGroup Boosts Quarterly Cash Dividend By 9% To $0.12/Shr; Record December 18/Payable January 3
10/22/2019 6:33:09 AM PulteGroup Q3 EPS $0.99 Vs $1.01 Last Year
10/17/2019 7:56:09 AM Wedbush Reiterates PulteGroup, Inc. (PHM) At Neutral With $34 Up From $28 Price Target
  
 
>